They found that dysregulation of LPA signalling as mediated by LPA specific G-protein-coupled receptors (LPAR), and more specifically LPAR3, may be associated with placental dysfunction in preeclampsia [65]. The gene discussed is LPAR3; the disease is preeclampsia.